A/Prof Velkov is one of world’s leaders in the discovery of novel polymyxin lipopeptides, their pharmacology, neuro-toxicology, mode of action and mechanisms of resistance. Collectively, his research has led to a substantial advancement of the scientific knowledge-base in these areas as attested to by his reports in leading journals in the field and multiple NIH grants.
The fundamental science in these areas underpins his international leadership in the field.
Find out more about Tony Velkov's experience
Tony Velkov's highlights
FEATURED Journal article
Outer Membranes of Polymyxin-Resistant Acinetobacter baumannii with Phosphoethanolamine-Modified Lipid A and Lipopolysaccharide Loss Display Different Atomic-Scale Interactions with Polymyxins.
Read moreTony Velkov's selected work
NOVEL OCTAPEPTIN ANTIBIOTICS TARGETING EXTREMELY DRUG RESISTANT 'SUPERBUGS'
Research Grant
A new weapon in the war against superbugs
NEWS ARTICLE
Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant..
Journal article
Pharmacology of intrathecal/intraventricular polymyxins: A systems-based approach
Research Grant
The chemical warfare against bacterial superbugs
NEWS ARTICLE
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-i..
Journal article
Tony Velkov's selected work
Projects
Displaying the 7 most recent projects by Tony Velkov.
Project Types
7
Research Grant
Additional Information
In the last 10-years A/Prof Velkov’s leadership and contribution to the field of antibiotics and drug discovery is demonstrable by the award of 5 NIH R01 grants (e.g. AI146241, AI098771, AI132154, Co-PD/PI, US
6.58M; and AI132681, AI111965, Co-I); 8 NHMRC project grants (e.g. 594875, 1064896, 1128891 CIA; 1085637, 606573, CIB) and NHMRC CDF Industry Fellowships in 2011 and 2015 (1009876, 1064896). Notably, he was awarded a large NIH R01 grant ( AI146241) as Co-PD/PI in 2019 which directly evolved from his industry related research programs: ‘Pharmacology of intrathecal/intraventricular polymyxins’, $2.4 M USD. The award of multiple NIH funds to an Australian researcher clearly demonstrates the international leadership of A/Prof Velkov and his team in antimicrobial research.Scholarly Works
Displaying the 10 most recent scholarly works by Tony Velkov.
Keyword Analysis
News
Displaying the 2 most recent news articles by Tony Velkov.
Honours, Awards and Fellowships
NHMRCF - NHMRC Fellowship
NHMRCF - NHMRC Fellowship
NHMRCF - NHMRC Fellowship
Credentials
Positions
Positions
Principal Research Fellow
Pharmacology And Therapeutics
Member
Australian Thoracic Society
Member
American Association for the Advancement of Science
Member
Australian Lung Foundation
Member
Australian Society for Biochemistry and Molecular Biology
Member
Australian Pharmaceutical Science Association
Organising Committee
Victorian Immunity and Infection Network Young Investigator Symposium
Member
American Chemical Society
Member
American Society of Microbiology
Member
American Protein Society
Member
Member of the Golden Key Honors Society
Education
Education
Monash University
Monash University